Detalles de la búsqueda
1.
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia.
Am J Hematol
; 90(3): E40-3, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25400215
2.
Involvement of antifactor VIII autoantibodies specificity in the outcome of inhibitor eradication therapies in acquired hemophilia a patients.
Blood Coagul Fibrinolysis
; 30(3): 127-132, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30958453
3.
Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency.
Thromb Haemost
; 116(1): 146-54, 2016 07 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27098529
4.
Successful immune tolerance induction with a plasma-derived FVIII concentrate and intravenous immunoglobulins in a pediatric patient with congenital severe hemophilia A and poor prognostic factors.
Blood Coagul Fibrinolysis
; 25(1): 77-80, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24231694
5.
Coexistence of three genetic risk factors in a Spanish thrombophilic family: Factor V Leiden, prothrombin 20210 and a new type I antithrombin deficiency.
Thromb Haemost
; 97(1): 153-5, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17200784
Resultados
1 -
5
de 5
1
Próxima >
>>